To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RBCK1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
484 representative clones for gene RBCK1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG327527 Kidney, renal cell adenocarcinoma .a 7 to 641 1 to 635   tiling clone,   635/635
(100 %)
3 diff
(99.6 %id)
BQ925061 epidermoid carcinoma, cell line, lung .a 8 to 766 27 to 789       761/932
(81 %)
11 diff
(98.9 %id)
BQ933980 epidermoid carcinoma, cell line, lung .a 10 to 736 1 to 729   tiling clone,   729/899
(81 %)
6 diff
(99.4 %id)
BG338542 leiomyosarcoma cell line, uterus .a 12 to 781 1 to 756       756/962
(78 %)
26 diff
(97.3 %id)
BU500916 eye, normal pigmented retinal epithelium .a 235 to 717 1 to 493       493/1137
(43 %)
23 diff
(98.0 %id)
AL523693 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 445 to 939 467 to 960   tiling clone,   957/1065
(89 %)
20 diff
(98.2 %id)
BM469963 lymph, lymphoma, cell line .a 875 to 1850 1 to 981   tiling clone,   981/1004
(97 %)
23 diff
(97.8 %id)
BG167164 hypernephroma, cell line, Kidney .a 1601 to 2186 26 to 611   tiling clone,   586/611
(95 %)
9 diff
(98.6 %id)
AL562241 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2153 to 2643 492 to 1   tiling clone,   492/492
(100 %)
13 diff
(97.4 %id)
NM_031229.2   .b 1 to 2760 1 to 2760 exact RefSeq, AAA   2760/2760
(100 %)
0 diff
(100 %id)
BC015219 Lung, large cell carcinoma .b 273 to 2760 1 to 2488 exact tiling clone, available from MGC, AAA   2488/2488
(100 %)
0 diff
(100 %id)
TI_1948244073   .b 717 to 1641 117 to 1037       921/1457
(63 %)
30 diff
(98.0 %id)
TI_1948244331   .b 717 to 1704 120 to 1101       982/1480
(66 %)
33 diff
(97.8 %id)
TI_1948244590   .b 717 to 1730 121 to 1129       1009/1499
(67 %)
41 diff
(97.3 %id)
TI_1948244856   .b 717 to 1618 119 to 1021       903/1453
(62 %)
22 diff
(98.5 %id)
BQ052558 blood, natural killer cells, cell line .b 844 to 1722 23 to 901       879/1046
(84 %)
17 diff
(98.4 %id)
NM_006462.4   .c 1 to 2615 1 to 2615 exact RefSeq, AAA   2615/2615
(100 %)
0 diff
(100 %id)
U67322   .c 99 to 2611 2 to 2512 exact tiling clone,   2511/2543
(98 %)
10 diff
(99.7 %id)
BX364054   .c 249 to 1234 1 to 986       986/986
(100 %)
10 diff
(99.0 %id)
CN262911 embryonic stem cells, cell lines H1, H7, andH9 .c 260 to 970 1 to 714       714/714
(100 %)
5 diff
(99.3 %id)
DN999422   .c 268 to 835 9 to 577       569/577
(98 %)
7 diff
(98.8 %id)
BX363807   .c 276 to 1406 1 to 1124       1126/1139
(98 %)
32 diff
(97.2 %id)
BE545757 cervical carcinoma cell line, cervix .c 297 to 978 1 to 690       690/757
(91 %)
29 diff
(96.2 %id)
BE541215 cervix .c 498 to 851 203 to 566   available from MGC,   527/972
(54 %)
34 diff
(96.6 %id)
CR996072 T-Lymphocytes .c 499 to 1080 1 to 583   tiling clone,   581/583
(99 %)
1 diff
(99.9 %id)
AB107766   .c 655 to 2615 1 to 1961 E194D AAA   1961/1961
(100 %)
1 diff
(100.0 %id)
TI_1948072643   .c 672 to 1126 122 to 576       455/966
(47 %)
8 diff
(99.2 %id)
TI_1948072644   .c 672 to 866 138 to 332       195/220
(88 %)
6 diff
(97.3 %id)
TI_1948072916   .c 672 to 1305 133 to 768       636/1302
(48 %)
15 diff
(98.9 %id)
TI_1948073203   .c 672 to 918 134 to 380       247/274
(90 %)
6 diff
(97.9 %id)
TI_1948073463   .c 672 to 906 132 to 366       235/260
(90 %)
6 diff
(97.7 %id)
CV029737 mixed .c 675 to 1257 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BC006572 Muscle, rhabdomyosarcoma .c 803 to 2615 1092 to 2904   tiling clone, AAA   1813/2904
(62 %)
0 diff
(100 %id)
BU540553 large cell carcinoma, lung .c 804 to 1691 1 to 889       889/891
(99 %)
11 diff
(98.8 %id)
CD516983 White Matter .c 809 to 1669 7 to 878       870/927
(93 %)
24 diff
(97.5 %id)
BQ687582 ductal carcinoma, cell line, Pancreas .c 873 to 1718 1 to 852       852/895
(95 %)
13 diff
(98.6 %id)
BG332052 large cell carcinoma, lung .c 908 to 1577 1 to 662       662/972
(68 %)
13 diff
(98.7 %id)
BQ918128 large cell carcinoma, lung .c 911 to 1850 1 to 942       942/942
(100 %)
9 diff
(99.1 %id)
BG684655 B-cells, primary B-cells from tonsils (cell line) .c 935 to 1701 1 to 767       767/771
(99 %)
5 diff
(99.4 %id)
BM811291 ovary (pool of 3) .c 971 to 1844 12 to 898       887/1116
(79 %)
27 diff
(97.6 %id)
BQ718224 sympathetic trunk .c 1017 to 1879 1 to 871       871/900
(96 %)
31 diff
(96.6 %id)
BQ932913 large cell carcinoma, lung .c 1083 to 1993 1 to 915       915/916
(99 %)
7 diff
(99.3 %id)
BQ890358 dorsal root ganglia .c 1111 to 1730 1 to 628       628/972
(64 %)
15 diff
(98.5 %id)
TI_1948244076   .c 1126 to 2080 1083 to 127       957/1376
(69 %)
26 diff
(98.2 %id)
TI_1948244334   .c 1126 to 2080 1084 to 129       956/1373
(69 %)
48 diff
(96.6 %id)
TI_1948244858   .c 1133 to 2080 1076 to 129       948/1402
(67 %)
35 diff
(97.6 %id)
BF689707 melanotic melanoma, high MDR (cell line), skin .c 1194 to 1881 1 to 689   fully sequenced,   689/689
(100 %)
9 diff
(98.7 %id)
BQ722348 sympathetic trunk .c 1253 to 2001 11 to 764       754/922
(81 %)
16 diff
(98.3 %id)
CR998598 T-Lymphocytes .c 1257 to 2077 1 to 825       822/825
(99 %)
6 diff
(99.3 %id)
BE873657 adenocarcinoma, colon .c 1283 to 2027 19 to 769       751/807
(93 %)
47 diff
(94.2 %id)
TI_1948244592   .c 1302 to 2080 904 to 125       780/1237
(63 %)
9 diff
(99.3 %id)
TI_1948244593   .c 1302 to 2080 905 to 126       780/1386
(56 %)
4 diff
(99.8 %id)
BQ652207 hepatocellular carcinoma, cell line, Liver .c 1316 to 2001 1 to 695       695/929
(74 %)
14 diff
(98.5 %id)
TI_1948244333   .c 1360 to 2080 849 to 124       726/1226
(59 %)
23 diff
(98.2 %id)
BG025051 lymph, lymphoma, cell line .c 1405 to 1993 30 to 621       592/626
(94 %)
18 diff
(97.2 %id)
BE379097 endometrium, adenocarcinoma cell line, uterus .c 1437 to 2246 1 to 812       812/813
(99 %)
12 diff
(98.6 %id)
AA135664 uterus .c 1552 to 1748 1 to 197       197/200
(98 %)
2 diff
(99.0 %id)
BX363806   .c 1577 to 2584 1016 to 1       1016/1016
(100 %)
34 diff
(96.7 %id)
H03870 placenta .c 1752 to 2121 1 to 378       378/378
(100 %)
22 diff
(94.2 %id)
BX352524   .c 1756 to 2604 856 to 10       847/856
(98 %)
34 diff
(96.1 %id)
BX374240   .c 1756 to 2613 856 to 1       856/905
(94 %)
15 diff
(98.4 %id)
BX412349.
matches multiple genes
placenta .c 1757 to 2602 845 to 1     also hits gene ASCL2 845/878
(96 %)
13 diff
(98.6 %id)
BI762580 pooled colon, kidney, stomach .c 1794 to 2595 1 to 813       813/813
(100 %)
24 diff
(97.1 %id)
TI_57150478   .c 1794 to 2595 31 to 843       813/843
(96 %)
27 diff
(96.8 %id)
TI_57176518   .c 1799 to 2463 31 to 707       677/835
(81 %)
42 diff
(95.0 %id)
BI829928 brain, medulla .c 1806 to 2463 1 to 670       670/798
(83 %)
36 diff
(95.5 %id)
BQ930732 epidermoid carcinoma, cell line, lung .c 1815 to 2616 1 to 807   AAA   807/807
(100 %)
20 diff
(97.6 %id)
BF690256 melanotic melanoma, high MDR (cell line), skin .c 1826 to 2591 769 to 1   fully sequenced,   769/769
(100 %)
8 diff
(99.0 %id)
AA481659 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1830 to 2313 1 to 479   fully sequenced,   479/479
(100 %)
5 diff
(99.0 %id)
AA447821 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1830 to 2257 1 to 426   fully sequenced,   426/426
(100 %)
6 diff
(98.6 %id)
BI061764 uterus_tumor .c 1841 to 2309 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
AV697398 hepatocellular carcinoma .c 1997 to 2615 1 to 612       612/706
(86 %)
10 diff
(98.6 %id)
AI951817 brain, four pooled pituitary adenomas .c 2000 to 2615 630 to 14   AAA   617/618
(99 %)
5 diff
(99.2 %id)
TI_154113029   .c 2000 to 2615 707 to 93   AAA   615/932
(65 %)
1 diff
(99.9 %id)
BU616162 Bone, Subchondral Bone .c 2000 to 2615 633 to 19   AAA   615/619
(99 %)
1 diff
(99.9 %id)
TI_154109137   .c 2029 to 2615 679 to 93   AAA   587/977
(60 %)
1 diff
(99.9 %id)
CA447652 Chondrosarcoma, Left Pelvis .c 2029 to 2615 605 to 19   AAA   587/594
(98 %)
1 diff
(99.9 %id)
BX367211   .c 2036 to 2603 571 to 1       571/612
(93 %)
16 diff
(97.4 %id)
AW370514 breast .c 2040 to 2399 23 to 381       359/381
(94 %)
6 diff
(98.5 %id)
BM794431 Ascites, stomach .c 2062 to 2605 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
BF805582 colon_ins .c 2066 to 2302 235 to 1     Submitted on the opposite strand 235/235
(100 %)
1 diff
(99.6 %id)
CN262907 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2067 to 2617 1 to 551       551/554
(99 %)
5 diff
(99.1 %id)
BF801205 colon_ins .c 2070 to 2264 327 to 133     Submitted on the opposite strand 195/327
(59 %)
0 diff
(100 %id)
TI_154014282   .c 2071 to 2615 663 to 130   AAA   534/1069
(49 %)
23 diff
(97.9 %id)
BU616624 Bone, Subchondral Bone .c 2085 to 2620 557 to 22   AAA   536/539
(99 %)
0 diff
(100 %id)
AA532754 adrenal adenoma, adrenal gland .c 2086 to 2613 541 to 15       527/541
(97 %)
0 diff
(100 %id)
BF939803 brain, glioblastoma (pooled) .c 2086 to 2614 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AW894865 nervous_normal .c 2110 to 2531 19 to 440       422/441
(95 %)
9 diff
(98.0 %id)
AI459551 brain, meningioma .c 2117 to 2531 416 to 2       415/416
(99 %)
0 diff
(100 %id)
CA392765 eye, RPE/choroid .c 2122 to 2615 1 to 494   AAA   494/494
(100 %)
0 diff
(100 %id)
EL953078 eyeball .c 2124 to 2617 1 to 494       494/498
(99 %)
2 diff
(99.6 %id)
AW027572 thymus, pooled .c 2125 to 2615 491 to 1       491/491
(100 %)
1 diff
(99.8 %id)
DB543960 hippocampus .c 2131 to 2614 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
BG166122 hypernephroma, cell line, Kidney .c 2138 to 2614 1 to 477   AAA   477/477
(100 %)
0 diff
(100 %id)
EC473330 Prostate .c 2141 to 2242 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
BG390100 embryonal carcinoma, cell line, testis .c 2146 to 2615 1 to 469   AAA   469/469
(100 %)
3 diff
(99.4 %id)
DB516919 testis .c 2152 to 2613 1 to 462     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
AI524227 B-cell, chronic lymphotic leukemia .c 2155 to 2621 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
DB519581 testis .c 2162 to 2613 1 to 452     Submitted on the opposite strand 452/452
(100 %)
0 diff
(100 %id)
AI085740 senescent fibroblast .c 2167 to 2615 449 to 1       449/449
(100 %)
0 diff
(100 %id)
BQ005436 Chondrosarcoma, Left Pelvis .c 2172 to 2606 461 to 28   AAA   434/443
(97 %)
0 diff
(100 %id)
AW104674 ovary, tumor, 5 pooled (see description) .c 2175 to 2615 453 to 13   AAA   441/441
(100 %)
0 diff
(100 %id)
AI082022 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2177 to 2617 446 to 6       441/446
(98 %)
0 diff
(100 %id)
BG978236 colon_ins .c 2188 to 2553 371 to 6       366/371
(98 %)
0 diff
(100 %id)
H03871 placenta .c 2206 to 2616 414 to 1       414/414
(100 %)
13 diff
(96.9 %id)
AW170696 bowel (skin primary), metastatic melanoma to bowel .c 2215 to 2615 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
AI014884   .c 2218 to 2615 408 to 12   AAA   397/397
(100 %)
4 diff
(99.0 %id)
AI284999 adenocarcinoma, colon .c 2224 to 2615 403 to 12   AAA   392/392
(100 %)
1 diff
(99.8 %id)
AA745875 germinal center B cell .c 2225 to 2554 329 to 1       329/329
(100 %)
3 diff
(99.1 %id)
AA447671 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2227 to 2615 387 to 1   fully sequenced,   387/387
(100 %)
2 diff
(99.5 %id)
AI032421 breast .c 2230 to 2618 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
AI358178 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 2232 to 2615 393 to 11   AAA   383/383
(100 %)
2 diff
(99.5 %id)
BQ576324 Chondrosarcoma Grade II, Left Pelvis .c 2232 to 2615 402 to 19   AAA   384/384
(100 %)
0 diff
(100 %id)
AA728754 pooled germ cell tumors .c 2234 to 2615 400 to 19   AAA   382/382
(100 %)
2 diff
(99.5 %id)
AA864632 germinal center B cell .c 2234 to 2615 401 to 21   AAA   381/381
(100 %)
18 diff
(95.3 %id)
AI631279 Kidney, renal cell tumor .c 2235 to 2615 414 to 34   AAA   381/381
(100 %)
17 diff
(95.6 %id)
AW411006 muscle, rhabdomyosarcoma .c 2245 to 2615 10 to 380   AAA   371/380
(97 %)
6 diff
(98.5 %id)
AA861084   .c 2256 to 2615 388 to 31   AAA   358/358
(100 %)
5 diff
(98.7 %id)
AA481421 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2283 to 2620 339 to 1   fully sequenced,   339/339
(100 %)
11 diff
(96.8 %id)
BM795020 Ascites, stomach .c 2287 to 2502 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
AI242363 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2295 to 2617 328 to 5       324/328
(98 %)
0 diff
(100 %id)
AW009316 colon .c 2322 to 2617 296 to 1       296/298
(99 %)
14 diff
(95.4 %id)
AA494132 colon .c 2328 to 2617 290 to 1       290/290
(100 %)
8 diff
(97.3 %id)
AA723082 heart .c 2347 to 2615 268 to 1       268/268
(100 %)
1 diff
(99.7 %id)
BE350341 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 2360 to 2615 271 to 16   AAA   256/256
(100 %)
3 diff
(98.9 %id)
AA991636 germ cell tumor .c 2366 to 2615 264 to 16   AAA   249/249
(100 %)
2 diff
(99.2 %id)
AI358467 adenocarcinoma, Pancreas .c 2385 to 2615 254 to 24   AAA   231/231
(100 %)
7 diff
(97.0 %id)
AI565926 adenocarcinoma, Pancreas .c 2391 to 2615 240 to 16   AAA   225/225
(100 %)
0 diff
(100 %id)
AI868060 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2393 to 2615 238 to 15   AAA   224/224
(100 %)
2 diff
(99.2 %id)
AI421788 brain, glioblastoma (pooled) .c 2408 to 2614 226 to 20   AAA   207/207
(100 %)
1 diff
(99.6 %id)
AI381710 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2410 to 2615 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
AA948718 2 pooled tumors (clear cell type), Kidney .c 2415 to 2617 209 to 6       204/211
(96 %)
0 diff
(100 %id)
AA729791 pooled germ cell tumors .c 2419 to 2615 214 to 19   AAA   196/196
(100 %)
1 diff
(99.5 %id)
AA862670 pooled germ cell tumors .c 2432 to 2617 185 to 1       185/185
(100 %)
3 diff
(98.4 %id)
AA524549 colon .c 2455 to 2615 177 to 18   AAA   160/160
(100 %)
1 diff
(99.4 %id)
AA135613 uterus .c 2475 to 2617 149 to 7       143/149
(95 %)
0 diff
(100 %id)
BI772442 pooled lung and spleen .d 1 to 754 1 to 753   tiling clone,   753/753
(100 %)
1 diff
(99.9 %id)
TI_57182185   .d 1 to 754 69 to 821       753/821
(91 %)
7 diff
(99.2 %id)
BG437262 large cell carcinoma, lung .d 32 to 734 1 to 709       707/758
(93 %)
13 diff
(98.3 %id)
BG490345 large cell carcinoma, lung .d 32 to 850 1 to 817   tiling clone,   817/817
(100 %)
5 diff
(99.4 %id)
AI909655 breast .d 793 to 1559 80 to 847   tiling clone,   768/847
(90 %)
14 diff
(98.4 %id)
CR625598 B cells (Ramos cell line) Cot 25-normalized .e 1 to 2174 1 to 2174 exact tiling clone,   2174/2174
(100 %)
0 diff
(100 %id)
AW630516 2 pooled high-grade transitional celltumors, genitourinary tract .e 7 to 295 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
BC000983 Placenta, choriocarcinoma .e 43 to 2206 1 to 2164 exact tiling clone, available from MGC, AAA   2164/2164
(100 %)
1 diff
(100.0 %id)
TI_1948073464   .e 421 to 1118 836 to 131       702/1337
(52 %)
22 diff
(98.4 %id)
TI_1948072646   .e 469 to 1118 781 to 130       652/1097
(59 %)
23 diff
(98.0 %id)
TI_1948073204   .e 472 to 1118 774 to 128       647/1298
(49 %)
10 diff
(99.3 %id)
TI_1948072917   .e 473 to 1118 775 to 127       649/1389
(46 %)
15 diff
(99.0 %id)
BX350722   .e 614 to 1471 857 to 1       857/857
(100 %)
11 diff
(98.8 %id)
TI_1948072645   .e 891 to 1118 356 to 129       228/255
(89 %)
0 diff
(100 %id)
BG284336 adenocarcinoma, cell line, Prostate .e 1039 to 1709 1 to 665       665/723
(91 %)
14 diff
(98.1 %id)
AW627488 2 pooled high-grade transitional celltumors, genitourinary tract .e 2014 to 2206 192 to 1       192/192
(100 %)
3 diff
(98.5 %id)
BC014116 Lung, large cell carcinoma .f 1 to 2750 1 to 2751 exact tiling clone, available from MGC, AAA   2751/2751
(100 %)
1 diff
(100.0 %id)
CA396625 eye, RPE/choroid .f 2 to 549 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BQ918903 large cell carcinoma, lung .f 4 to 729 1 to 735       735/863
(85 %)
19 diff
(97.8 %id)
BU540658 large cell carcinoma, lung .f 4 to 873 1 to 874       874/893
(97 %)
8 diff
(99.2 %id)
BU146566 dorsal root ganglia .f 16 to 885 1 to 880       880/913
(96 %)
27 diff
(97.1 %id)
BX384569   .f 17 to 471 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
BQ948128 eye, normal pigmented retinal epithelium .f 17 to 730 1 to 714       714/891
(80 %)
2 diff
(99.8 %id)
BF686298 leiomyosarcoma cell line, uterus .f 20 to 869 1 to 845       845/1157
(73 %)
35 diff
(97.0 %id)
CB851012 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 24 to 158 135 to 1       135/143
(94 %)
0 diff
(100 %id)
BX366828 Placenta Cot 25-normalized .f 29 to 875 1 to 843       843/843
(100 %)
16 diff
(98.2 %id)
BQ936448 carcinoma, cell line, Prostate .f 29 to 860 1 to 842       842/934
(90 %)
22 diff
(97.7 %id)
BE563206 adenocarcinoma, Pancreas .f 33 to 730 1 to 699       699/849
(82 %)
11 diff
(98.8 %id)
DB450418 testis .f 34 to 494 1 to 458       458/458
(100 %)
3 diff
(99.4 %id)
BI116949 lung, small cell carcinoma .f 34 to 647 1 to 631       631/797
(79 %)
23 diff
(97.2 %id)
BG110659 Bone, osteosarcoma, cell line .f 35 to 871 1 to 836       836/927
(90 %)
24 diff
(97.5 %id)
BG575749 breast, mammary adenocarcinoma, cell line .f 36 to 859 1 to 843       843/845
(99 %)
42 diff
(95.1 %id)
BG747460 adenocarcinoma cell line, colon .f 36 to 682 1 to 646       646/647
(99 %)
4 diff
(99.4 %id)
BU186758 large cell carcinoma, lung .f 37 to 646 1 to 616       616/864
(71 %)
13 diff
(98.5 %id)
TI_57180558   .f 42 to 786 27 to 771       745/772
(96 %)
9 diff
(98.9 %id)
BU177560 melanotic melanoma, skin .f 46 to 787 1 to 746       746/838
(89 %)
9 diff
(99.0 %id)
BI768107 pooled lung and spleen .f 47 to 786 1 to 741       741/742
(99 %)
17 diff
(97.8 %id)
BP385614 pancreatic islet .f 50 to 531 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BE393124 endometrium, adenocarcinoma cell line, uterus .f 54 to 670 1 to 618       618/624
(99 %)
8 diff
(98.8 %id)
BE891479 melanotic melanoma, skin .f 55 to 536 1 to 484       484/484
(100 %)
9 diff
(98.2 %id)
CX757158 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 59 to 734 1 to 665     Submitted on the opposite strand 665/716
(92 %)
16 diff
(97.8 %id)
BG329133 eye, retinoblastoma .f 97 to 870 1 to 771       774/1084
(71 %)
26 diff
(97.7 %id)
BE251809 eye, retinoblastoma .f 117 to 730 1 to 616       616/730
(84 %)
8 diff
(99.0 %id)
BU183176 melanotic melanoma, skin .f 137 to 807 25 to 696       672/926
(72 %)
12 diff
(98.8 %id)
BM741231 stomach .f 205 to 781 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BM745781 stomach .f 205 to 305 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
BM765752 stomach .f 205 to 626 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BM765789 stomach .f 205 to 788 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BM766075 stomach .f 205 to 642 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BG478538 melanotic melanoma, skin .f 221 to 1019 1 to 816       814/881
(92 %)
37 diff
(95.9 %id)
DR003321 fetal brain .f 244 to 787 1 to 546       546/546
(100 %)
12 diff
(97.9 %id)
DB475131 hippocampus .f 250 to 728 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
DA503695 brain .f 251 to 798 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA626701 Kidney .f 251 to 665 2 to 416   capped   415/415
(100 %)
1 diff
(99.8 %id)
DA910631   .f 251 to 786 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DB160373 thymus .f 251 to 830 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB161118 thymus .f 251 to 842 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
BM761565 myeloma .f 253 to 644 1 to 392       392/392
(100 %)
1 diff
(99.8 %id)
BM784635 myeloma .f 253 to 633 1 to 381       381/381
(100 %)
0 diff
(100 %id)
CN262917 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 254 to 866 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
DA516398 brain .f 256 to 725 2 to 472   capped   471/471
(100 %)
1 diff
(99.8 %id)
DA689339   .f 256 to 798 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA511831 brain .f 257 to 814 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA951007 Spleen .f 257 to 821 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BG718570 testis .f 258 to 1050 8 to 796       789/806
(97 %)
11 diff
(98.7 %id)
CA487408   .f 259 to 885 1 to 629       629/954
(65 %)
10 diff
(99.0 %id)
DB454143 testis .f 262 to 749 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
AL521827 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 265 to 1104 1 to 839       839/839
(100 %)
6 diff
(99.3 %id)
BX401730   .f 265 to 1288 1 to 1025       1025/1028
(99 %)
33 diff
(96.8 %id)
TI_57235141   .f 265 to 1058 34 to 831       798/831
(96 %)
14 diff
(98.4 %id)
BX458907 placenta .f 266 to 1260 4 to 995       992/995
(99 %)
20 diff
(98.0 %id)
BX386751   .f 266 to 1247 4 to 974       971/974
(99 %)
15 diff
(98.5 %id)
BI908257 leukocyte .f 266 to 1058 1 to 797       797/797
(100 %)
9 diff
(98.9 %id)
BU164504 large cell carcinoma, lung .f 266 to 868 12 to 619       608/997
(60 %)
16 diff
(98.4 %id)
CN262906 embryonic stem cells, DMSO-treated H9 cellline .f 267 to 506 1 to 240       240/240
(100 %)
2 diff
(99.2 %id)
BI518679 leukocyte .f 267 to 1132 1 to 873       873/993
(87 %)
32 diff
(96.8 %id)
TI_44459855   .f 267 to 1132 86 to 958       873/1078
(80 %)
34 diff
(96.9 %id)
TI_57230753   .f 267 to 1119 49 to 899       851/851
(100 %)
10 diff
(98.9 %id)
AL556771 placenta .f 268 to 1176 1 to 897       851/962
(88 %)
46 diff
(95.3 %id)
BI871614 adenocarcinoma, cell line, Liver .f 268 to 1119 1 to 850       850/850
(100 %)
10 diff
(98.9 %id)
DN997478 breast cancer, Mammary gland (cancer tissue) .f 268 to 699 1 to 432       432/432
(100 %)
4 diff
(99.1 %id)
TI_57175991   .f 269 to 1075 62 to 866       805/866
(92 %)
8 diff
(99.1 %id)
CN262914 embryonic stem cells, cell lines H1, H7, andH9 .f 271 to 947 1 to 678       678/678
(100 %)
4 diff
(99.5 %id)
AL548707 placenta, Placenta Cot 25-normalized .f 271 to 1241 1 to 962       962/986
(97 %)
14 diff
(98.6 %id)
BI820740 pooled brain, lung, testis .f 273 to 997 1 to 725       725/725
(100 %)
0 diff
(100 %id)
TI_57197415   .f 273 to 997 68 to 792       725/792
(91 %)
6 diff
(99.3 %id)
BM805639 brain, hippocampus .f 275 to 1028 1 to 761       761/1013
(75 %)
13 diff
(98.8 %id)
BI829636 brain, medulla .f 276 to 1075 1 to 798       798/798
(100 %)
4 diff
(99.5 %id)
CK431000 eye, lacrimal gland .f 276 to 898 1 to 623       623/623
(100 %)
0 diff
(100 %id)
CX759404 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 277 to 1043 1 to 758     Submitted on the opposite strand 758/766
(98 %)
13 diff
(98.4 %id)
BU540444 large cell carcinoma, lung .f 278 to 1144 1 to 872       872/904
(96 %)
10 diff
(98.9 %id)
BX366985   .f 279 to 1133 1 to 854       854/854
(100 %)
3 diff
(99.7 %id)
BM920785 pooled brain, lung, testis .f 279 to 1144 1 to 868       868/1056
(82 %)
14 diff
(98.7 %id)
BX395013 Neuroblastoma Cot 25-normalized .f 281 to 1242 1 to 958       958/959
(99 %)
17 diff
(98.3 %id)
AW404473 lymph .f 281 to 653 1 to 373       373/373
(100 %)
4 diff
(99.0 %id)
BX376487 Neuroblastoma Cot 25-normalized .f 283 to 1146 1 to 862       862/872
(98 %)
5 diff
(99.5 %id)
BI754210 brain .f 283 to 1058 1 to 775       775/775
(100 %)
3 diff
(99.7 %id)
TI_57217478   .f 283 to 1058 81 to 855       775/855
(90 %)
6 diff
(99.3 %id)
BG323683 Kidney, renal cell adenocarcinoma .f 287 to 1025 1 to 734       734/816
(89 %)
10 diff
(98.8 %id)
CR977169 T-Lymphocytes .f 287 to 968 1 to 681       681/689
(98 %)
3 diff
(99.6 %id)
DB137626 thymus .f 287 to 838 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG325980 Kidney, renal cell adenocarcinoma .f 288 to 1063 1 to 782       782/1048
(74 %)
28 diff
(97.4 %id)
CR978012 T-Lymphocytes .f 288 to 811 1 to 526       526/526
(100 %)
2 diff
(99.7 %id)
CR994541 T-Lymphocytes .f 288 to 768 1 to 481       481/485
(99 %)
2 diff
(99.6 %id)
DA380020 thalamus .f 289 to 839 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BG120350 adenocarcinoma, cell line, Liver .f 290 to 1071 1 to 776       774/1000
(77 %)
30 diff
(97.0 %id)
CF141485 CNCAP(3)T-225 cell line, Prostate .f 293 to 779 1 to 487       487/487
(100 %)
5 diff
(99.0 %id)
CR996233 T-Lymphocytes .f 294 to 946 1 to 653       653/655
(99 %)
1 diff
(99.9 %id)
BQ949463 large cell carcinoma, lung .f 296 to 1167 1 to 875       875/911
(96 %)
13 diff
(98.6 %id)
TI_154172218   .f 298 to 872 78 to 652       575/611
(94 %)
8 diff
(98.7 %id)
ES308987 occipital hair of pubic hypotrichosispatient, skin .f 303 to 611 1 to 309       309/309
(100 %)
4 diff
(98.8 %id)
AL541910 placenta .f 305 to 1388 1 to 1079       1079/1083
(99 %)
13 diff
(98.8 %id)
DN995517 breast cancer, Mammary gland (cancer tissue) .f 305 to 1023 9 to 727       719/727
(98 %)
6 diff
(99.2 %id)
CN262916 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 309 to 603 1 to 296       296/296
(100 %)
3 diff
(99.0 %id)
BP422695 small intestine .f 309 to 798 1 to 492     Submitted on the opposite strand 490/492
(99 %)
5 diff
(99.0 %id)
CN262910 embryonic stem cells, cell lines H1, H7, andH9 .f 315 to 477 1 to 163       163/163
(100 %)
2 diff
(98.8 %id)
BE734912 choriocarcinoma, placenta .f 317 to 1107 818 to 35     Submitted on the opposite strand 784/944
(83 %)
29 diff
(97.0 %id)
BQ073028 leukocyte .f 317 to 1174 17 to 878       862/1058
(81 %)
18 diff
(98.3 %id)
CR974677 T-Lymphocytes .f 317 to 655 1 to 339       339/346
(97 %)
1 diff
(99.8 %id)
CR995873 T-Lymphocytes .f 317 to 898 1 to 582       582/583
(99 %)
1 diff
(99.9 %id)
BQ957585 large cell carcinoma, lung .f 319 to 979 44 to 705       662/970
(68 %)
14 diff
(98.6 %id)
BM761558 myeloma .f 319 to 812 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BM851836 stomach .f 319 to 706 1 to 388       388/388
(100 %)
1 diff
(99.8 %id)
BI911427 leukocyte .f 326 to 1054 28 to 759       732/759
(96 %)
17 diff
(97.8 %id)
TI_57232242   .f 326 to 1054 28 to 759       732/759
(96 %)
17 diff
(97.8 %id)
CR995250 T-Lymphocytes .f 326 to 931 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
DA843350 placenta .f 328 to 890 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BQ221417 large cell carcinoma, lung .f 332 to 1151 1 to 824       824/871
(94 %)
15 diff
(98.3 %id)
CR985475 T-Lymphocytes .f 334 to 869 1 to 536       536/537
(99 %)
1 diff
(99.9 %id)
BX357212 Placenta Cot 25-normalized .f 335 to 1040 1 to 705       705/705
(100 %)
2 diff
(99.8 %id)
BF797876 lymph, lymphoma, cell line .f 335 to 965 1 to 631       631/867
(72 %)
9 diff
(99.0 %id)
BE734560 choriocarcinoma, placenta .f 337 to 1110 798 to 33     Submitted on the opposite strand 766/1035
(74 %)
31 diff
(97.1 %id)
BE733506 choriocarcinoma, placenta .f 342 to 1091 741 to 1     Submitted on the opposite strand 741/910
(81 %)
15 diff
(98.4 %id)
CR996724 T-Lymphocytes .f 343 to 1167 1 to 825       825/828
(99 %)
1 diff
(99.9 %id)
BG327502 Kidney, renal cell adenocarcinoma .f 345 to 754 1 to 415       415/415
(100 %)
7 diff
(98.4 %id)
BG420021 Kidney, renal cell adenocarcinoma .f 345 to 1118 1 to 772       772/956
(80 %)
18 diff
(98.2 %id)
AW408512 lymph .f 377 to 751 1 to 375       375/375
(100 %)
5 diff
(98.7 %id)
BE732500 choriocarcinoma, placenta .f 419 to 1091 673 to 1     Submitted on the opposite strand 673/673
(100 %)
1 diff
(99.9 %id)
BE273132 Kidney, renal cell adenocarcinoma .f 423 to 982 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
BG773927 choriocarcinoma, placenta .f 423 to 1110 689 to 2     Submitted on the opposite strand 688/690
(99 %)
1 diff
(99.9 %id)
TI_57242209   .f 433 to 1260 89 to 914       826/914
(90 %)
7 diff
(99.3 %id)
BI917302 brain .f 442 to 1260 1 to 817       817/817
(100 %)
2 diff
(99.8 %id)
BE732019 choriocarcinoma, placenta .f 451 to 1077 1 to 627       627/627
(100 %)
0 diff
(100 %id)
EC475681 Prostate .f 456 to 560 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BQ650244 hepatocellular carcinoma, cell line, Liver .f 576 to 1430 2 to 860       859/990
(86 %)
27 diff
(97.3 %id)
BQ646242 hepatocellular carcinoma, cell line, Liver .f 585 to 1392 1 to 807       807/881
(91 %)
18 diff
(98.0 %id)
TI_59390620   .f 608 to 1442 98 to 927       833/834
(99 %)
37 diff
(95.6 %id)
TI_59390672   .f 608 to 1398 87 to 880       794/796
(99 %)
29 diff
(96.4 %id)
BM020943 astrocytoma grade IV, cell line, brain .f 609 to 1292 1 to 684       684/795
(86 %)
11 diff
(98.7 %id)
BM020894 astrocytoma grade IV, cell line, brain .f 609 to 1442 1 to 829       832/833
(99 %)
37 diff
(95.6 %id)
BM050336 eye, normal pigmented retinal epithelium .f 641 to 1307 1 to 676       674/759
(88 %)
28 diff
(96.4 %id)
CA487886   .f 648 to 1434 1 to 792       792/895
(88 %)
14 diff
(98.5 %id)
CD243808 testis .f 663 to 1395 7 to 758       750/900
(83 %)
35 diff
(96.2 %id)
BQ894977 sciatic nerve .f 676 to 1442 1 to 772       772/914
(84 %)
16 diff
(98.3 %id)
TI_57183064   .f 676 to 1461 58 to 844       787/942
(83 %)
18 diff
(98.1 %id)
BG748607 eye, normal pigmented retinal epithelium .f 680 to 1550 1 to 878       878/879
(99 %)
24 diff
(97.3 %id)
BI771521 pooled lung and spleen .f 685 to 1555 1 to 876       876/876
(100 %)
22 diff
(97.5 %id)
BI024486 marrow .f 704 to 951 247 to 1       247/247
(100 %)
4 diff
(98.4 %id)
TI_1948244591   .f 732 to 1575 130 to 971       842/1270
(66 %)
18 diff
(98.6 %id)
BG420200 Kidney, renal cell adenocarcinoma .f 808 to 1608 1 to 807       805/924
(87 %)
24 diff
(97.5 %id)
BG107283 lymph, lymphoma, cell line .f 853 to 1450 1 to 597       599/645
(92 %)
12 diff
(98.2 %id)
CN262909 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 873 to 1129 1 to 257       257/257
(100 %)
1 diff
(99.7 %id)
BI870682 adenocarcinoma, cell line, Liver .f 1604 to 2348 1 to 742       742/742
(100 %)
6 diff
(99.2 %id)
TI_57230143   .f 1604 to 2348 88 to 829       742/742
(100 %)
6 diff
(99.2 %id)
BG249724 hypernephroma, cell line, Kidney .f 1615 to 2390 1 to 773       773/813
(95 %)
31 diff
(96.2 %id)
N99547 liver and spleen .f 1643 to 2130 1 to 496       494/499
(98 %)
17 diff
(96.6 %id)
CD633038   .f 1686 to 2430 765 to 14       750/770
(97 %)
6 diff
(99.3 %id)
CD633039   .f 1712 to 2224 14 to 526       513/526
(97 %)
6 diff
(98.9 %id)
AL569164 placenta .f 1712 to 2708 993 to 1       993/996
(99 %)
18 diff
(98.2 %id)
BX395012 Neuroblastoma Cot 25-normalized .f 1715 to 2714 994 to 1       994/994
(100 %)
25 diff
(97.5 %id)
BX401729   .f 1715 to 2716 1032 to 1       834/1037
(80 %)
53 diff
(94.9 %id)
BE895827 melanotic melanoma, skin .f 1715 to 2347 1 to 632       632/632
(100 %)
5 diff
(99.3 %id)
BX401195   .f 1719 to 2689 969 to 1       969/969
(100 %)
30 diff
(97.0 %id)
BX364053   .f 1719 to 2718 990 to 1       990/990
(100 %)
21 diff
(97.9 %id)
BI870767 adenocarcinoma, cell line, Liver .f 1742 to 2292 12 to 564       553/564
(98 %)
8 diff
(98.6 %id)
TI_57228503   .f 1742 to 2679 65 to 1013       949/982
(96 %)
45 diff
(95.5 %id)
AL578948 placenta .f 1766 to 2721 947 to 1       947/992
(95 %)
31 diff
(96.9 %id)
CA406999 adipose .f 1769 to 2267 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
BX376486 Neuroblastoma Cot 25-normalized .f 1781 to 2709 958 to 5       896/958
(93 %)
14 diff
(98.6 %id)
BQ927611 large cell carcinoma, lung .f 1783 to 2585 1 to 809       809/955
(84 %)
11 diff
(98.9 %id)
CN262918 embryonic stem cells, DMSO-treated H9 cellline .f 1788 to 2091 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BG176576 lymph, lymphoma, cell line .f 1788 to 2417 1 to 626       626/959
(65 %)
10 diff
(99.0 %id)
BQ435844 melanotic melanoma, skin .f 1798 to 2456 1 to 671       671/994
(67 %)
10 diff
(99.0 %id)
CN262908 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1801 to 2437 1 to 637       637/637
(100 %)
3 diff
(99.6 %id)
BX366984   .f 1820 to 2716 895 to 1       895/899
(99 %)
12 diff
(98.7 %id)
AL521826 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 1837 to 2698 898 to 41       858/898
(95 %)
5 diff
(99.5 %id)
BE385583 melanotic melanoma, skin .f 1866 to 2506 1 to 646       646/649
(99 %)
11 diff
(98.4 %id)
TI_57231269   .f 1876 to 2731 47 to 901       855/855
(100 %)
11 diff
(98.8 %id)
BI869254 adenocarcinoma, cell line, Liver .f 1877 to 2292 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BX357211 Placenta Cot 25-normalized .f 1960 to 2721 759 to 1       759/759
(100 %)
3 diff
(99.7 %id)
AJ707150 heart .f 2014 to 2546 18 to 550       533/550
(96 %)
7 diff
(98.8 %id)
AL573173 placenta, Placenta Cot 25-normalized .f 2068 to 2721 657 to 1       657/833
(78 %)
16 diff
(98.1 %id)
BG006889 placenta_normal .f 2099 to 2380 282 to 1       282/283
(99 %)
1 diff
(99.7 %id)
CA313511 Human Lung Epithelial cells, lung .f 2105 to 2750 664 to 19   AAA   646/646
(100 %)
1 diff
(99.9 %id)
BM676204 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 2105 to 2750 663 to 19   AAA   645/646
(99 %)
2 diff
(99.7 %id)
BM995897 Chondrosarcoma, Left Pubic Bone .f 2111 to 2741 656 to 28   AAA   629/638
(98 %)
0 diff
(100 %id)
CA448636 Chondrosarcoma, Left Pelvis .f 2116 to 2750 651 to 19   AAA   633/633
(100 %)
4 diff
(99.4 %id)
N71538 liver and spleen .f 2607 to 2750 182 to 38   AAA   145/145
(100 %)
1 diff
(99.4 %id)
TI_57233321   .g 1 to 752 30 to 781   tiling clone,   752/783
(96 %)
9 diff
(98.9 %id)
BI906849 leukocyte .g 7 to 752 1 to 746   tiling clone,   746/748
(99 %)
5 diff
(99.4 %id)
BQ948642 sciatic nerve .g 61 to 732 1 to 676   tiling clone,   676/941
(71 %)
17 diff
(98.2 %id)
EB385621 eye, optic nerve .g 730 to 1421 1 to 692   tiling clone,   692/692
(100 %)
1 diff
(99.9 %id)
BF796338 lymph, lymphoma, cell line .h 1 to 731 1 to 728   tiling clone,   728/953
(76 %)
7 diff
(99.3 %id)
BF974899 B-cells, primary B-cells from tonsils (cell line) .h 415 to 1108 1 to 693       693/712
(97 %)
15 diff
(97.9 %id)
BG984369 colon_normal .h 465 to 977 539 to 27       513/539
(95 %)
7 diff
(98.8 %id)
BG984370 colon_normal .h 506 to 967 467 to 5       463/467
(99 %)
7 diff
(98.6 %id)
CR608145 Placenta Cot 25-normalized .h 536 to 1838 1 to 1303   tiling clone,   1303/1303
(100 %)
0 diff
(100 %id)
BX399760 Placenta Cot 25-normalized .h 537 to 1285 1 to 749       749/1047
(71 %)
5 diff
(99.6 %id)
BM695238 eye, optic nerve .h 654 to 1274 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
BF948751 nervous_normal .h 798 to 1246 5 to 453       449/453
(99 %)
6 diff
(98.7 %id)
AA381704   .h 929 to 1176 1 to 248       248/248
(100 %)
1 diff
(99.6 %id)
BX399759 Placenta Cot 25-normalized .h 1278 to 1838 558 to 1       558/1052
(53 %)
9 diff
(99.2 %id)
BM666414 eye, optic nerve .h 1284 to 1899 633 to 19   tiling clone, AAA   615/618
(99 %)
2 diff
(99.7 %id)
AI672722 thymus, pooled .i 1 to 292 46 to 337   tiling clone, AAA Submitted on the opposite strand 292/337
(86 %)
6 diff
(98.3 %id)
BG340084 leiomyosarcoma cell line, uterus .i 136 to 728 1 to 594   tiling clone,   594/594
(100 %)
2 diff
(99.7 %id)
TI_1948244074   .i 400 to 1136 134 to 869       736/1318
(55 %)
20 diff
(98.5 %id)
TI_1948244332   .i 400 to 1106 128 to 836       709/1340
(52 %)
17 diff
(98.8 %id)
EL733180 mixed .i 407 to 1059 1 to 653       653/653
(100 %)
7 diff
(99.0 %id)
BE267763 Burkitt lymphoma, lymph .i 429 to 1020 1 to 593       593/594
(99 %)
10 diff
(98.4 %id)
BE396413 Burkitt lymphoma, lymph .i 429 to 1109 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
CR996309 T-Lymphocytes .i 431 to 1163 1 to 735   tiling clone,   735/736
(99 %)
2 diff
(99.8 %id)
CR982525 T-Lymphocytes .i 467 to 996 1 to 530       530/532
(99 %)
1 diff
(99.9 %id)
BF806841 colon_ins .i 1075 to 1394 323 to 5   tiling clone, Submitted on the opposite strand 319/323
(98 %)
0 diff
(100 %id)
BG999846 head_normal .i 1149 to 1602 490 to 35       456/490
(93 %)
0 diff
(100 %id)
BI000199 head_normal .i 1314 to 1528 47 to 258       258/258
(100 %)
18 diff
(93.1 %id)
BG014899 placenta_normal .i 1317 to 1625 52 to 360   tiling clone,   309/360
(85 %)
6 diff
(98.4 %id)
BF843162 head_neck .i 1336 to 1675 339 to 1   tiling clone, Submitted on the opposite strand 339/339
(100 %)
3 diff
(99.2 %id)
BF803072 colon_ins .i 1344 to 1530 1 to 191       191/275
(69 %)
8 diff
(97.1 %id)
CN262912 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 1 to 740 1 to 740 exact tiling clone,   740/740
(100 %)
0 diff
(100 %id)
DA997136   .k 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
BE895578 melanotic melanoma, skin .k 25 to 670 1 to 629       624/1157
(53 %)
49 diff
(95.8 %id)
BE387204 melanotic melanoma, skin .k 31 to 714 29 to 715       687/716
(95 %)
7 diff
(99.1 %id)
CA424663 cell lines, Chondrosarcoma .k 457 to 1022 584 to 19   tiling clone, AAA   566/566
(100 %)
1 diff
(99.9 %id)
AW977723   .k 473 to 1021 550 to 1   tiling clone, Submitted on the opposite strand 550/589
(93 %)
11 diff
(98.2 %id)
BQ716862 dorsal root ganglia .l 1 to 732 1 to 742   tiling clone,   742/880
(84 %)
15 diff
(98.3 %id)
CN262905 embryonic stem cells, cell lines H1, H7, andH9 .l 99 to 801 1 to 704   tiling clone,   704/704
(100 %)
6 diff
(99.2 %id)
BI093606 cervix .l 296 to 1049 1 to 769   tiling clone,   769/771
(99 %)
55 diff
(92.9 %id)
CX757833 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .l 366 to 1088 1 to 724   tiling clone, Submitted on the opposite strand 724/724
(100 %)
32 diff
(95.6 %id)
BF956783 nervous_normal .l 639 to 1003 1 to 364   tiling clone,   364/364
(100 %)
9 diff
(97.6 %id)
AI904266 breast .l 648 to 1044 1 to 396   tiling clone,   396/397
(99 %)
20 diff
(95.0 %id)
AW877418 pnet .l 665 to 872 210 to 1   tiling clone,   210/210
(100 %)
6 diff
(97.2 %id)
BF849906 lung_normal .l 678 to 1003 15 to 342       328/342
(95 %)
6 diff
(98.3 %id)
CX871055 embryonic stem .l 1045 to 1278 1 to 234   tiling clone,   234/234
(100 %)
1 diff
(99.6 %id)
AV693939 hepatocellular carcinoma .l 1135 to 1545 1 to 410       410/411
(99 %)
7 diff
(98.3 %id)
BM853194 Ascites, stomach .l 1209 to 1681 1 to 473 exact tiling clone,   473/473
(100 %)
0 diff
(100 %id)
BI056351 placenta_normal .l 1212 to 1383 175 to 4       172/187
(91 %)
0 diff
(100 %id)
AA148164 Pancreas .m 1 to 336 1 to 341       341/365
(93 %)
24 diff
(93.5 %id)
BQ054948 lymph, lymphoma, cell line .m 2 to 665 1 to 680   tiling clone,   680/1080
(62 %)
28 diff
(97.5 %id)
BM312117 Pancreas, Purified pancreatic islet .m 15 to 513 10 to 508       499/508
(98 %)
6 diff
(98.9 %id)
BE866889 adenocarcinoma, colon .m 23 to 793 1 to 761 D8M H10T S11A H12T A13P ...     761/923
(82 %)
21 diff
(97.8 %id)
BQ678938 melanotic melanoma, cell line, skin .m 36 to 587 1 to 552       552/893
(61 %)
13 diff
(98.6 %id)
CK821828 Pancreas, Purified pancreatic islet .m 46 to 644 1 to 599   tiling clone, Submitted on the opposite strand 599/599
(100 %)
1 diff
(99.9 %id)
BE890484 melanotic melanoma, skin .m 76 to 717 1 to 641       641/644
(99 %)
9 diff
(98.7 %id)
CK821829 Pancreas, Purified pancreatic islet .m 227 to 811 595 to 11 H60Y AAA Submitted on the opposite strand 585/585
(100 %)
1 diff
(99.9 %id)
BM311519 Pancreas, Purified pancreatic islet .m 362 to 810 449 to 1 H60Y     449/449
(100 %)
1 diff
(99.8 %id)
AA258002 germinal center B cell .m 412 to 812 399 to 3   tiling clone,   397/399
(99 %)
1 diff
(99.8 %id)
AW951525   .m 426 to 811 1 to 386   tiling clone, AAA   386/386
(100 %)
5 diff
(98.8 %id)
AA384067 thyroid gland .m 432 to 758 1 to 329       329/329
(100 %)
5 diff
(98.5 %id)
AA148165 Pancreas .m 457 to 811 371 to 14   AAA   358/361
(99 %)
5 diff
(98.7 %id)
AA113058 Pancreas .n 1 to 372 1 to 376   tiling clone,   376/379
(99 %)
9 diff
(97.7 %id)
AA113141 Pancreas .n 479 to 897 419 to 1   tiling clone,   419/419
(100 %)
3 diff
(99.3 %id)
BC016301 Pancreas, adenocarcinoma .o 1 to 1186 1 to 1186 exact tiling clone, available from MGC, AAA   1186/1186
(100 %)
1 diff
(100.0 %id)
BU508041 leiomyosarcoma, uterus .o 16 to 924 1 to 913       911/1181
(77 %)
31 diff
(97.4 %id)
TI_57149011   .o 22 to 896 30 to 906       877/906
(96 %)
13 diff
(98.6 %id)
BI761599 pooled colon, kidney, stomach .o 28 to 896 1 to 872       872/872
(100 %)
8 diff
(99.1 %id)
BU197040 ductal carcinoma, cell line, Pancreas .o 184 to 1002 1 to 829 R75K K76E R78K T80D P81T ...     829/908
(91 %)
17 diff
(98.2 %id)
BM910950 astrocytoma grade IV, cell line, brain .o 207 to 951 1 to 753       753/1151
(65 %)
16 diff
(98.7 %id)
BM809806 astrocytoma grade IV, cell line, brain .o 207 to 1044 1 to 842 D54G R56Q L58P M59H V60G ...     842/1128
(74 %)
38 diff
(96.7 %id)
AK309414 brain .o 215 to 1186 1 to 972 exact     972/972
(100 %)
0 diff
(100 %id)
AL558241 T cells from T cell leukemia .o 225 to 1144 4 to 920 E24K L34H A35G E36R Q37X ...     917/920
(99 %)
25 diff
(97.3 %id)
BE730198 melanotic melanoma, skin .o 229 to 1009 33 to 824 K7Q A8S E9R E10G M11H ...     790/1076
(73 %)
36 diff
(96.7 %id)
BF306224 muscle, rhabdomyosarcoma .o 231 to 1018 1 to 775 L13*     775/784
(98 %)
24 diff
(97.0 %id)
BF306048 muscle, rhabdomyosarcoma .o 231 to 929 1 to 692       692/693
(99 %)
11 diff
(98.5 %id)
AA160708 Pancreas .o 232 to 788 1 to 541   fully sequenced,   541/541
(100 %)
22 diff
(96.0 %id)
AA160679 Pancreas .o 232 to 803 1 to 556   fully sequenced,   556/556
(100 %)
21 diff
(96.3 %id)
CV574515 cornea, eye .o 232 to 841 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BM050375 eye, normal pigmented retinal epithelium .o 236 to 1005 1 to 776 R75T K76E R78K K79Q T80R ...     776/776
(100 %)
14 diff
(98.2 %id)
BG770976 adenocarcinoma, Prostate .o 238 to 977 1 to 740       740/740
(100 %)
11 diff
(98.6 %id)
TI_57163366   .o 238 to 872 34 to 667       634/667
(95 %)
11 diff
(98.4 %id)
BI116988 lung, small cell carcinoma .o 239 to 1020 1 to 786 Q69P P70A S71I H72T H73S ...     786/786
(100 %)
16 diff
(98.0 %id)
BI909394 leukocyte .o 242 to 840 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
TI_57233658   .o 242 to 840 30 to 627       598/627
(95 %)
6 diff
(99.1 %id)
BQ645613 hepatocellular carcinoma, cell line, Liver .o 243 to 1106 1 to 875 R75E K76E R78E K79E T80R ...     875/898
(97 %)
21 diff
(97.7 %id)
BI837924 pooled pancreas and spleen .o 246 to 872 1 to 625       625/625
(100 %)
6 diff
(99.1 %id)
CD050724 embryonic trophoblasts, made from WA01 stemcells .o 248 to 1079 23 to 860 K87E Q91X     838/873
(95 %)
19 diff
(97.9 %id)
BM467583 lymph, lymphoma, cell line .o 248 to 883 36 to 675       637/1247
(51 %)
18 diff
(98.6 %id)
BE796585 lung, small cell carcinoma .o 251 to 960 1 to 710       710/710
(100 %)
5 diff
(99.3 %id)
BQ688614 ductal carcinoma, cell line, Pancreas .o 259 to 973 1 to 722       722/851
(84 %)
13 diff
(98.5 %id)
BQ689519 ductal carcinoma, cell line, Pancreas .o 259 to 1072 1 to 819 Q91X     819/824
(99 %)
8 diff
(99.1 %id)
BG165713 hypernephroma, cell line, Kidney .o 266 to 1067 1 to 787 S14R L15P T16H R17P A18S ...     787/977
(80 %)
32 diff
(96.8 %id)
AA148155 colon, tumor .o 268 to 652 1 to 396       396/403
(98 %)
33 diff
(91.9 %id)
BM051935 Burkitt lymphoma, lymph .o 273 to 978 1 to 709       709/710
(99 %)
12 diff
(98.4 %id)
AA133149 Pancreas .o 274 to 477 1 to 204       204/207
(98 %)
7 diff
(96.7 %id)
BE737188 adenocarcinoma, Pancreas .o 283 to 973 38 to 720   AAA   683/997
(68 %)
16 diff
(98.4 %id)
CT003281 T-Lymphocytes .o 293 to 915 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BE561027 Burkitt lymphoma, lymph .o 294 to 1068 1 to 777 K76N R78K T80D P81T L82P ...     777/938
(82 %)
19 diff
(98.0 %id)
CR989913 T-Lymphocytes .o 294 to 1081 1 to 788 A27V     788/788
(100 %)
2 diff
(99.8 %id)
BQ961742 epithelioid carcinoma cell line, Pancreas .o 296 to 1178 1 to 892 exact     892/904
(98 %)
21 diff
(97.7 %id)
TI_57168128   .o 304 to 1003 27 to 731 I68N S71I H72T H73S R74Q ...     705/809
(87 %)
31 diff
(96.2 %id)
BI834831 pooled pancreas and spleen .o 309 to 1003 1 to 700 I68N S71I H72T H73S R74Q ...     700/778
(89 %)
27 diff
(96.6 %id)
BU181202 large cell carcinoma, lung .o 331 to 1086 1 to 761 L93M     761/930
(81 %)
19 diff
(98.0 %id)
BQ689367 ductal carcinoma, cell line, Pancreas .o 334 to 1187 1 to 865 R75E K76E R78K T80D P81T ... AAA   865/865
(100 %)
19 diff
(97.9 %id)
TI_154148244   .o 343 to 902 81 to 639       559/559
(100 %)
11 diff
(98.1 %id)
BU500180   .o 410 to 1186 1 to 777 exact AAA   777/777
(100 %)
1 diff
(99.9 %id)
BG762648 melanotic melanoma, high MDR (cell line), skin .o 442 to 1128 1 to 691 E36R Q37A R38T V39G P40A ...     691/691
(100 %)
8 diff
(98.9 %id)
CB159452 Liver .o 461 to 938 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CA426546 cell lines, Chondrosarcoma .o 491 to 1186 714 to 19 Q25P AAA   696/696
(100 %)
2 diff
(99.8 %id)
CB529133 Aveolar Macrophage, lung .o 518 to 1186 687 to 19 exact AAA   669/669
(100 %)
1 diff
(99.9 %id)
BP431806   .o 546 to 959 1 to 414       414/414
(100 %)
5 diff
(98.8 %id)
CD368138 Alveolar Macrophage, lung .o 550 to 1186 656 to 19 exact AAA   638/638
(100 %)
2 diff
(99.7 %id)
CN262913 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 559 to 1057 1 to 500 exact     500/500
(100 %)
1 diff
(99.8 %id)
AW610123 stomach .o 583 to 1138 559 to 3 T84S     557/561
(99 %)
1 diff
(99.9 %id)
AA148142 colon, tumor .o 613 to 1066 1 to 458 L15S T16P R17E A18Q V19W ...     458/468
(97 %)
19 diff
(96.0 %id)
AI421818 brain, glioblastoma (pooled) .o 626 to 1187 561 to 1 exact     561/561
(100 %)
3 diff
(99.5 %id)
BG283129 adenocarcinoma, cell line, Prostate .o 626 to 1187 1 to 561 exact     561/582
(96 %)
4 diff
(99.4 %id)
BU608175 Human Lung Epithelial cells, lung .o 673 to 1186 532 to 19   AAA   514/523
(98 %)
1 diff
(99.9 %id)
BU608182 Human Lung Epithelial cells, lung .o 673 to 1186 532 to 19   AAA   514/523
(98 %)
1 diff
(99.9 %id)
BP394263 pancreatic islet .o 684 to 1182 1 to 499     Submitted on the opposite strand 499/499
(100 %)
6 diff
(98.8 %id)
BP391084 pancreatic islet .o 688 to 1187 1 to 500   tiling clone, Submitted on the opposite strand 500/502
(99 %)
1 diff
(99.9 %id)
AA779450   .o 698 to 1166 493 to 25       469/493
(95 %)
1 diff
(99.8 %id)
AA576609 colon, colon tumor RER+ .o 698 to 1187 493 to 3       491/493
(99 %)
3 diff
(99.4 %id)
AA916689 carcinoid, lung .o 698 to 1186 489 to 1       489/489
(100 %)
6 diff
(98.8 %id)
AI129703 uterus .o 698 to 1187 490 to 1       490/490
(100 %)
1 diff
(99.8 %id)
AI367391 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .o 698 to 1186 489 to 1       489/489
(100 %)
3 diff
(99.4 %id)
AI741869 pooled .o 698 to 1187 494 to 4       491/494
(99 %)
0 diff
(100 %id)
AI963073 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o 698 to 1187 491 to 1       491/491
(100 %)
3 diff
(99.4 %id)
AW028549 fibrotheoma, ovary .o 698 to 1187 501 to 7       495/501
(98 %)
6 diff
(98.9 %id)
BE675077 B-cell, chronic lymphotic leukemia .o 698 to 1170 506 to 27       480/506
(94 %)
0 diff
(100 %id)
BF057565 fibrotheoma, ovary .o 698 to 1186 486 to 1       486/486
(100 %)
2 diff
(99.6 %id)
AA713493 germinal center B cell .o 701 to 1186 497 to 11   AAA   487/489
(99 %)
9 diff
(98.2 %id)
AA946829 2 pooled tumors (clear cell type), Kidney .o 701 to 1187 488 to 3       486/491
(98 %)
4 diff
(99.2 %id)
BE788439 large cell carcinoma, lung .o 705 to 1187 1 to 487       487/905
(53 %)
12 diff
(98.7 %id)
BM987188 mixed .o 710 to 1186 495 to 19   AAA   477/477
(100 %)
0 diff
(100 %id)
AI267942 carcinoid, lung .o 719 to 1186 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
AW610173 stomach .o 725 to 1124 1 to 400       400/414
(96 %)
3 diff
(99.3 %id)
AI310475 2 pooled tumors (clear cell type), Kidney .o 725 to 1187 469 to 7       463/469
(98 %)
0 diff
(100 %id)
AI380468 B-cell, chronic lymphotic leukemia .o 725 to 1186 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
AI343961 colon, colon tumor, RER+ .o 729 to 1186 460 to 1       460/460
(100 %)
3 diff
(99.4 %id)
AI222994 pooled .o 740 to 1187 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
AI269080 Kidney .o 740 to 1187 450 to 3       448/450
(99 %)
1 diff
(99.8 %id)
AI360705 pooled germ cell tumors .o 746 to 1186 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AA074969   .o 751 to 1187 1 to 436       436/438
(99 %)
10 diff
(97.8 %id)
AA159501 Pancreas .o 759 to 1187 431 to 3   fully sequenced,   429/431
(99 %)
0 diff
(100 %id)
AI971817 fibrotheoma, ovary .o 769 to 1186 442 to 27   AAA   416/457
(91 %)
5 diff
(99.0 %id)
AA143784 colon, tumor .o 771 to 1187 424 to 3       422/424
(99 %)
4 diff
(99.1 %id)
BX115684 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .o 773 to 1186 428 to 15   AAA   414/414
(100 %)
2 diff
(99.6 %id)
AA159513 Pancreas .o 773 to 1187 419 to 4   fully sequenced,   416/419
(99 %)
0 diff
(100 %id)
AA587011 larynx .o 799 to 1187 391 to 3       389/391
(99 %)
0 diff
(100 %id)
BQ213577 large cell carcinoma, lung .o 811 to 1186 12 to 387   AAA   376/387
(97 %)
8 diff
(98.0 %id)
BE739319 hypernephroma, Kidney .o 822 to 1185 1 to 363   AAA   363/363
(100 %)
2 diff
(99.5 %id)
BE739566 hypernephroma, Kidney .o 822 to 1114 332 to 40       293/332
(88 %)
0 diff
(100 %id)
AW276485 lung, two pooled squamous cell carcinomas .o 835 to 1187 353 to 1       353/353
(100 %)
0 diff
(100 %id)
AI832932 colon .o 838 to 1187 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AI471701 colon, moderately-differentiated adenocarcinoma .o 843 to 1187 350 to 6       345/350
(98 %)
0 diff
(100 %id)
AI032200 carcinoid, lung .o 844 to 1186 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
AA810644 germinal center B cell .o 848 to 1164 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
AI985117 Kidney .o 880 to 1187 313 to 6       308/313
(98 %)
0 diff
(100 %id)
AA069145 Pancreas .o 893 to 1187 302 to 4       299/302
(99 %)
0 diff
(100 %id)
T99066 liver and spleen .o 895 to 1178 293 to 1       293/297
(98 %)
10 diff
(96.7 %id)
AA860157   .o 897 to 1187 294 to 5       290/294
(98 %)
0 diff
(100 %id)
AA057758 colon, tumor .o 908 to 1187 285 to 2       284/286
(99 %)
0 diff
(100 %id)
AI284729 ovary, tumor, 5 pooled (see description) .o 924 to 1187 264 to 2       263/264
(99 %)
0 diff
(100 %id)
AA133119 Pancreas .o 925 to 1186 266 to 1       266/268
(99 %)
8 diff
(97.1 %id)
AI186346 placenta .o 926 to 1187 260 to 2       259/260
(99 %)
0 diff
(100 %id)
AI766498 colon, colon tumor, RER+ .o 927 to 1187 264 to 2       263/264
(99 %)
0 diff
(100 %id)
AW273710 lung, two pooled squamous cell carcinomas .o 929 to 1187 268 to 9       260/268
(97 %)
0 diff
(100 %id)
AI339901 adenocarcinoma, colon .o 998 to 1187 196 to 7       190/196
(96 %)
0 diff
(100 %id)
AW151341 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .o 998 to 1186 189 to 1       189/189
(100 %)
0 diff
(100 %id)
AA845942 Spleen .o 1025 to 1128 104 to 1       104/104
(100 %)
0 diff
(100 %id)
AA053006 colon, tumor .o 1075 to 1186 112 to 1       112/113
(99 %)
0 diff
(100 %id)
AA877342 colon, colon tumor RER+ .o 1113 to 1187 80 to 6       75/80
(93 %)
0 diff
(100 %id)
CR994956 T-Lymphocytes .p 1 to 939 1 to 938 P108Q K109X Q114R E115N G117D ... tiling clone,   938/944
(99 %)
7 diff
(99.3 %id)
BI006339 kidney_tumor .p 239 to 386 1 to 149   tiling clone,   149/149
(100 %)
1 diff
(99.4 %id)
DA520864 brain .q-u 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
125 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI